Laguna Hills-based Alacrity Biosciences announced today that it has raised $8.45M in a private financing. Investors in the company were not disclosed, however the funding took the form of a convertible note. Paramount BioCapital was the placement agent in the deal. The firm said the funding will go towards development of the firm's treatments for opthalmic diseases.
Top NewsMonday, March 5, 2007
Alacrity Biosciences Raises $8.45M In Debt